High expression of FOXD2-AS1 could promote the progression of cancer cell, including proliferation, migration, and invasion [31–35], and could be prognostic biomarker for many cancers, such as oral squamous cell carcinoma, head and neck squamous cell carcinoma, renal cancer [36–38]. This evidence concerns the gene FOXD2 and head and neck squamous cell carcinoma.